D. Wakao

Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation.

M Taniwaki, M. Taniwaki, A. Matsuda, 2001, Cancer research.

Fusion of ETV 6 to Fibroblast Growth Factor Receptor 3 in Peripheral T-Cell Lymphoma with a t ( 4 ; 12 ) ( p 16 ; p 13 ) Chromosomal Translocation 1

M. Taniwaki, A. Matsuda, M. Bessho, 2001 .

Serum levels of Thl/Th2 cytokines, angiogenic growth factors, and other prognostic factors in young adult patients with hemophagocytic syndrome.

I. Jinnai, A. Matsuda, M. Bessho, 2006, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.

Takashi Takahashi, A. Matsuda, M. Bessho, 2002, Leukemia research.

Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.

Takashi Takahashi, I. Jinnai, A. Matsuda, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma

M. Bessho, K. Hirashima, F. Yagasaki, 2002, Annals of Hematology.

Serum Thymidine Kinase and Soluble Interleukin-2 Receptor Levels Predict Subclinical Recurrence of Malignant Lymphoma

D. Wakao, 2004 .